CVS Health Corp. buy Subdi
Summary
This prediction ended on 16.07.22 with a price of €95.19. The BUY prediction by Subdi for CVS Health Corp. saw massive gains of 99.31%. Dividends of €6.21 are taken into consideration when calculating the performance. Subdi has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CVS Health Corp. | 8.282% | 8.282% | 27.201% | 21.377% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% | 50.284% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% | 107.459% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% | 76.350% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% | 72.625% |
Comments by Subdi for this prediction
In the thread CVS Health Corp. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 09.03.2019 der Buy-Einschätzung von tamam mit dem Kursziel 85$ zu.
Überschrift: tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu